Febbraio 4, 2009
2009
web@zerimarketing.com
Budget Impact Analysis nel trattamento della depressione maggiore nelle diverse regioni Italiane: il ruolo di Venlafaxina
Autori: Giorgio L. Colombo, Sergio Di Matteo Venlafaxine (Efexor – Wyeth) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment of major depressive disorder (MDD). Following patent expiration, venlafaxine is available as generic at a reduced price. To evaluate the overall savings to the National Health System (NHS) following venlafaxine’s price reduction, a Budget [...]